LX4211, a Dual Inhibitor of SGLT2 and SGLT1 Enhances the Effects of Sitagliptin in Patients With Type 2 Diabetes Mellitus (T2DM)

被引:0
|
作者
Zambrowicz, Brian
Ogbaa, Ike
Powell, David
Banks, Phillip
Turnage, Anne
Frazier, Kenny
Boehm, Kristi A.
Freiman, Joel
Lapuerta, Pablo
Sands, Arthur
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
974-P
引用
收藏
页码:A248 / A249
页数:2
相关论文
共 50 条
  • [21] Effect of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, on Systolic Blood Pressure in Patients with Type 2 Diabetes
    Hardin, Marquette
    Davies, Michael
    Carroll, Amy
    Umpierrez, Guillermo
    CIRCULATION, 2024, 150
  • [22] Discovery of a Novel Dual SGLT1 and SGLT2 Inhibitor for Diabetes Therapy
    Xu, Yao-Chang
    Li, Chenghai
    Wang, Juanjuan
    Liao, Jianchun
    Gao, Peng
    Bao, Rudi
    Yu, Hongping
    DIABETES, 2015, 64 : A660 - A660
  • [23] Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
    Sands, Arthur T.
    Zambrowicz, Brian P.
    Rosenstock, Julio
    Lapuerta, Pablo
    Bode, Bruce W.
    Garg, Satish K.
    Buse, John B.
    Banks, Phillip
    Heptulla, Rubina
    Rendell, Marc
    Cefalu, William T.
    Strumph, Paul
    DIABETES CARE, 2015, 38 (07) : 1181 - 1188
  • [24] Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus
    Cui, Haigang
    Luo, Xin
    Chen, Mingwei
    Lu, Jun
    Liu, Johnson J. J.
    CURRENT DRUG TARGETS, 2023, 24 (08) : 648 - 661
  • [25] SGLT2 blockers in T2DM
    Barranco, Caroline
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 255 - 255
  • [26] Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus ( vol 6, 2300143, 2023)
    Azizogli, Abdul-Rahman
    Vitti, Michael R.
    Mishra, Richa
    Osorno, Laura
    Heffernan, Corey
    Kumar, Vivek A.
    ADVANCED THERAPEUTICS, 2024, 7 (09)
  • [27] SGLT2 blockers in T2DM
    Caroline Barranco
    Nature Reviews Cardiology, 2018, 15 : 255 - 255
  • [28] SGLT2抑制剂LX4211的合成方法研究
    王瑞
    马宗辉
    许宁
    刘明媚
    徐莉英
    宫平
    中国药物化学杂志, 2014, 24 (06) : 464 - 469
  • [29] The SGLT2 Inhibitor Visual Tour: Bringing Visuals to Increase Prescribing for CKD Plus Type 2 Diabetes Mellitus (T2DM)
    Sundaram, Sruthi
    Bhandary, Siddartha
    Waheed, Sana
    Johnson, Sarah Ann
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [30] Survey to Specify SGLT2 Inhibitor Choice in T2DM Management
    Ghosal, Samit
    Joshi, Radhika M.
    Iyer, Rahul N.
    Adsule, Samir M.
    CLINICAL DIABETOLOGY, 2022, 11 (05): : 326 - 332